Clearmind Medicine, Inc. (CMND)
1.93
+0.17
(+9.66%)
USD |
NASDAQ |
Aug 31, 16:00
1.93
0.00 (0.00%)
After-Hours: 17:24
Clearmind Medicine Free Cash Flow : -6.292M for April 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| April 30, 2026 | -6.292M |
| January 31, 2026 | -5.597M |
| October 31, 2025 | -4.778M |
| July 31, 2025 | -4.603M |
| April 30, 2025 | -4.557M |
| January 31, 2025 | -4.647M |
| October 31, 2024 | -4.843M |
| July 31, 2024 | -4.413M |
| April 30, 2024 | -4.747M |
| January 31, 2024 | -4.618M |
| October 31, 2023 | -6.260M |
| July 31, 2023 | -5.702M |
| April 30, 2023 | -4.496M |
| January 31, 2023 | -5.534M |
| October 31, 2022 | -3.841M |
| July 31, 2022 | -5.303M |
| Date | Value |
|---|---|
| April 30, 2022 | -5.423M |
| January 31, 2022 | -3.778M |
| October 31, 2021 | -2.439M |
| July 31, 2021 | -0.9435M |
| April 30, 2021 | -0.6472M |
| January 31, 2021 | -0.2804M |
| October 31, 2020 | -0.2076M |
| July 31, 2020 | -0.1545M |
| April 30, 2020 | -0.1163M |
| January 31, 2020 | -0.0342M |
| October 31, 2019 | -0.0552M |
| July 31, 2019 | -0.1294M |
| April 30, 2019 | -0.1665M |
| January 31, 2019 | -0.1774M |
| October 31, 2018 | -0.1818M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| InMed Pharmaceuticals, Inc. | -7.710M |
| NervGen Pharma Corp. | -18.43M |
| Milestone Pharmaceuticals, Inc. | -61.10M |
| Lexaria Bioscience Corp. | -7.527M |
| Target Group, Inc. (Canada) | -1.168M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.792M |
| Cash from Investing (Quarterly) | -0.6541M |
| Cash from Financing (Quarterly) | 4.653M |
| Free Cash Flow Per Share (Quarterly) | -5.934 |
| Free Cash Flow to Equity (Quarterly) | -1.870M |
| Free Cash Flow to Firm (Quarterly) | -1.788M |
| Free Cash Flow Yield | -2.92K% |